Non Hodgkin Lymphoma News and Research

RSS
FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

Infographic displays facts and information about stem cells, cord blood

Infographic displays facts and information about stem cells, cord blood

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Differential RNA splicing may play role in prostate cancer disparities in African-American men

Differential RNA splicing may play role in prostate cancer disparities in African-American men

FDA authorizes marketing of test to aid in diagnoses of serious cancers

FDA authorizes marketing of test to aid in diagnoses of serious cancers

AMSBIO introduce range of cancer exosome samples

AMSBIO introduce range of cancer exosome samples

Study finds steady decline in severe health problems for childhood cancer survivors

Study finds steady decline in severe health problems for childhood cancer survivors

Study finds no clear benefit of stem-cell transplant for double-hit lymphoma patients in remission

Study finds no clear benefit of stem-cell transplant for double-hit lymphoma patients in remission

Scientists announce ‘outstanding’ results of new blood cancer study

Scientists announce ‘outstanding’ results of new blood cancer study

Second cancers are far deadlier in younger people than older adults

Second cancers are far deadlier in younger people than older adults

Differences found in cancer occurrence within African and US born blacks

Differences found in cancer occurrence within African and US born blacks

Number of HIV-positive cancer patients in the U.S. projected to decrease through 2030

Number of HIV-positive cancer patients in the U.S. projected to decrease through 2030

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

Study identifies potential risks for mothers who are cancer survivors

Study identifies potential risks for mothers who are cancer survivors

UNC Lineberger achieves major milestone with launch of cellular immunotherapy program

UNC Lineberger achieves major milestone with launch of cellular immunotherapy program

Researchers examine risk factors for B Cell Non-Hodgkin Lymphoma in Israeli, Palestinian populations

Researchers examine risk factors for B Cell Non-Hodgkin Lymphoma in Israeli, Palestinian populations

Prolonged exposure to work-related stress linked to increased risk of cancers

Prolonged exposure to work-related stress linked to increased risk of cancers

Study shows promising results for treating lymphoma patients with immune cell therapy

Study shows promising results for treating lymphoma patients with immune cell therapy

UNMC seeking patients with lymphoma to evaluate two-drug oral therapy

UNMC seeking patients with lymphoma to evaluate two-drug oral therapy

Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma

Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma